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cantly associated with a disease duration of  ^  8 years (p = 
0.03). Gender and type of IBD were not significantly associ-
ated with patients’ preferences.  Conclusions: This study 
demonstrates IBD patients’ desire to be actively involved in 
the decision-making process. Further research is needed on 
physicians’ perspectives on shared decision-making, and on 
finding predictive factors for developing a model for shared 
decision-making in IBD.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Shared decision-making is increasingly advocated as 
an ideal model of treatment decision-making  [1–3] . In 
this model the physician has the responsibility to inform 
the patients and give them advice, whereas the actual de-
cisions on how to act on this information are made in 
collaboration between the patient and physician  [4] .
 Patients and physicians vary substantially in the de-
gree to which they are comfortable with patients’ involve-
ment in decision-making  [5, 6] . The literature available 
on patients’ preferences of shared decision-making has 
mainly focused on healthy persons or restricted popula-
tions, especially cancer patients  [7–11] . Other studies are 
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 Abstract 
 Background: Shared decision-making is gaining favor in 
clinical practice, although the extent to which patients want 
to be involved in choosing their treatment varies substan-
tially. Because data are lacking on the preferences of patients 
with chronic diseases such as inflammatory bowel disease 
(IBD), we wanted to assess IBD patients’ preferences about 
being involved in such decisions.  Methods: Adult IBD pa-
tients were asked to anonymously complete an online sur-
vey on their preferences. Non-parametric tests (  2 ) were 
used to determine the relationship between responses and 
respondents.  Results: The questionnaire was completed by 
1,067 patients, 617 with Crohn’s disease and 450 with ulcer-
ative colitis. Patients’ mean age was 43 (SD 13.7) years; the 
majority were female (66%). In total, 866 patients (81%) re-
ported it as ‘very important’ to be actively involved in the 
decision-making process, and another 177 (17%) rated it as 
‘quite important’. When asked how their treatment could be 
improved, 537 patients (50%) wanted close, equitable col-
laboration with their physician. This preference was signifi-
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limited by small sample sizes or hypothetical scenarios 
 [12–14] . Patients’ information needs and decision-mak-
ing can change during treatment, as demonstrated in 
breast cancer patients  [15] . Healthy persons’ preferences 
can therefore not be extrapolated to sick patients who 
need medicinal treatment.
 Patients with chronic diseases may have different 
preferences regarding shared decision-making than 
healthy patients who are put in a hypothetical scenario. 
A systematic review of the effects of shared decision-
making suggested that shared decision-making is espe-
cially suitable for long-term decisions and/or in case of a 
chronic disease  [16] . However, further data on the prefer-
ences of patients with inflammatory bowel disease (IBD) 
are lacking.
 IBD is the heading for two major chronic gastrointes-
tinal diseases of unknown origin: ulcerative colitis (UC) 
and Crohn’s disease (CD). In 2004, as many as 1.4 million 
persons in the United States and 2.2 million persons in 
Europe suffered from these diseases  [17] . The incidence 
of IBD has been increasing over the years, which for UC 
varies greatly between 0.5 and 24.5/10 5 inhabitants, and 
for CD varies between 0.1 and 16/10 5 inhabitants world-
wide  [18, 19] . The prevalence rates of IBD reach up to 
396/10 5 inhabitants  [19] . Patients with IBD have a de-
creased quality of life, both influenced by symptoms and 
treatments  [20, 21] . Several therapeutic strategies, includ-
ing the wide use of immunosuppressants, have been ad-
vocated in the treatment of these chronic diseases, each 
with its own risks and benefits  [22] .
 Patient-empowerment is becoming increasingly im-
portant in the management of chronic diseases  [23] . This 
model posits that patients are responsible for their choic-
es and also the consequences of their choices. As a result 
of empowerment, patients may develop a greater sense of 
self-efficacy regarding various disease and treatment-re-
lated behaviors, and may express changes in life priorities 
and values. Due to empowerment, patients are also ex-
pected to better self-manage not only their disease, but 
also their lives  [24] . It has been suggested that patients 
show better adherence when they are actively involved in 
the decision-making process  [5, 16] . Non-adherence is an 
important reason for relapsing disease in IBD  [25] . Shared 
decision-making can therefore be used to educate pa-
tients about the utmost importance of adherence to med-
ication and the necessity to commit and follow-through 
on their treatment.
 It is unknown to what extent IBD patients actually 
want to be involved in decision-making regarding the 
most appropriate therapeutic strategy for their disease. 
The purpose of this patient-empowerment study was to 
assess IBD patients’ preferences with regard to their in-
volvement in the decision of treatment choices.
 Methods 
 Questionnaire 
 A patient-empowerment study was performed in collaboration 
with the Dutch Patients’ Association of Crohn’s disease and Ulcer-
ative Colitis (CCUVN). A questionnaire was developed by mem-
bers of the CCUVN working in close collaboration with a panel of 
IBD patients not associated with the CCUVN. During several 
meetings, patients discussed the issues of shared decision-making 
and questioned to what extent they wanted to be involved in the 
decision-making about their treatment strategies. The question-
naire mirrors the outcome of these discussions. After the ques-
tionnaire had been framed, an independent physician advised the 
panel on the scientific and medical content of the questionnaire.
 In close-ended questions, patients were asked how they as-
sessed a possible active involvement in the decision-making of 
their own treatment. In open-ended questions patients were asked 
what they should know or receive from their treating physicians 
in order to be better treated for their disease. After pilot testing 
on a panel of IBD patients, the questionnaire was further opti-
mized. This panel consists of IBD patients whose opinions are 
regularly solicited for such purposes and therefore have an exten-
sive expertise on evaluating questionnaires. The questionnaire is 
listed in the appendix.
 CCUVN Respondents 
 The definitive questionnaire was placed on the website of the 
CCUVN from December 2006 to January 2007. The CCUVN has 
approximately 10,250 members, of whom 9,509 have registered 
their gender and age. Of these 9,509 registered CCUVN members, 
65% are female and 66% are  ^  50 years old. Adult IBD patients 
were asked to fill out the questionnaire anonymously.
 A randomly selected group of patients from our outpatient 
IBD clinic was used to confirm the representativeness of the in-
ternet population. Patients were asked to fill out the questionnaire 
before they visited their physician and were assured their answers 
would stay anonymous. Patients who had already cooperated in 
the online questionnaire were excluded.
 Statistical Analysis 
 Statistical analysis was performed using descriptive statistics 
and   2 tests. Ordinal survey items were compared using non-
parametric tests (  2 ). Groups were compared based on age, gender 
and duration of disease, which was subdivided into  ^  8 years of 
disease and  1 8 years of disease. The cutoff of 8 years concerning 
duration of disease was chosen by the panel of IBD patients. The 
patients decided to divide duration of disease into 4 categories 
(0–2, 3–8, 9–15, and  1 15 years). For statistical purposes this was 
combined in 2 groups, ‘short duration of disease’ and ‘long dura-
tion of disease’. Mann-Whitney U tests were used to assess differ-
ences in responses among the online group and the outpatient 
clinic group. The statistical software SPSS version 15.0 for Win-
dows was used for all statistical analyses.
Shared Decision-Making in the 
Treatment of IBD 
Digestion 2010;81:113–119 115
 Results 
 Study Population 
 In total, 1,093 patients filled out the questionnaire on-
line. Twenty-six patients were excluded from analysis due 
to lack of information on their type of IBD (n = 24) or on 
their gender (n = 2). Patient characteristics are shown in 
 table 1 . Of the 1,067 patients included in the analysis, 617 
had CD (58%) and 450 had UC (42%). The mean age of 
patients was 42.9 (SD 13.7) years old, the duration of dis-
ease was  1 8 years in 575 patients (54%), and 703 patients 
(66%) were female.
 The CCUVN has approximately 10,250 members, of 
whom 9,509 have registered their gender and age. Of all 
members, 10% filled out our questionnaire which, in ad-
dition, is fully representative of all CCUVN members 
with regard to age and gender. Of the 9,509 registered 
CCUVN members, 65% are female and 66% are  ^  50 
years old, which is comparable to the demographics in 
our group (66% female; mean age 43 years).
 Patients’ Satisfaction with Current Practice 
 In total, 980 patients (92%) were satisfied or very satis-
fied with the extent to which their physician currently 
involves them in the decision-making concerning their 
medical treatment ( table 2 ). With regard to the time and 
attention given by the physician during visits to the out-
patient clinic, 949 patients (89%) were at least ‘satisfied’. 
The current medical treatment as prescribed by the treat-
ing physician could be improved according to 216 pa-
tients (20%). Patients’ suggestions to improve current 
treatment are listed in  table 3 .
 Active Involvement in Decision-Making Is Very 
Important for IBD Patients 
 Patients’ assessments of the involvement in the deci-
sion-making are shown in  figure 1 . In total, 866 patients 
(81%) called it ‘very important’ to be actively involved in 
the decision-making regarding their medical treatment 
options. Another 177 patients (17%) rated active involve-
ment in this decision process as ‘quite important’.
 Patients Require Close Collaboration with Physicians 
to Improve Treatment Regimen 
 When asked what is important for patients to be better 
treated for their disease, 537 patients (50%) requested a 
close-equitable collaboration with their physician ( ta-
ble 3 ). Duration of disease was significantly associated 
with this response: 307 of 575 patients with  ^  8 years of 
disease (53%) against 230 of 492 patients (47%) with  1 8 
years of disease (p = 0.03) wanted good collaboration with 
the physician to be based on equivalence ( fig. 2 ). In an-
swer to this same question, 289 patients (27%) suggested 
a checklist to fill out in order to improve their current 
treatment regimen, again in close collaboration with 
their physician. This was also significantly associated 
Table 1. Patient characteristics
Online group Outpatient
clinic group
Number 1,067 169
Disease
Crohn’s disease 617 (58%) 125 (74%)
Ulcerative colitis 450 (42%) 41 (24%)
Unclassified colitis – 3 (2%)
Female gender 703 (66%) 84 (50%)
Mean age 8 SD, years 42.9813.7 38.7814.4
Duration of disease
0–2 years 179 (17%) 22 (13%)
3–8 years 313 (29%) 54 (32%)
9–15 years 277 (26%) 43 (25%)
>15 years 298 (28%) 50 (30%)
Decreased quality of life 531 (50%) 100 (59%)
Member CCUVN 1,001 (94%) 61 (36%)
Table 2. Patients’ satisfaction concerning current treatment in the 
online group compared with the outpatient clinic group
Online
group
Outpatient
clinic group
p value
Satisfaction with current involvement in treatment?
Very satisfied 665 (62%) 110 (65%)
Satisfied 315 (30%) 42 (25%)
Dissatisfied 54 (5%) 8 (5%) n.s.
Very dissatisfied 33 (3%) 2 (1%)
No answer given – 7 (4%)
Satisfaction time and attention from physician during clinic visit?
Very satisfied 674 (63%) 118 (70%)
Satisfied 275 (26%) 38 (22.5%)
Dissatisfied 90 (8%) 10 (5.9%) 0.04
Very dissatisfied 28 (3%) 1 (1%)
No answer given – 2 (1%)
Could the current medical treatment prescribed by physician be 
improved?
Yes 216 (20%) 33 (20%)
No 851 (80%) 120 (71%) n.s.
No answer given – 16 (10%)
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with the duration of disease: 24% (140/575) of the patients 
with a short duration of disease ( ^  8 years) against 30% 
(149/492) of the patients with a long duration of disease 
( 1 8 years) suggested this option of a checklist (p = 0.03). 
In total, 579 patients (54%) wanted more information on 
new medication options in order to improve their treat-
ment; 496 patients (47%) wanted more knowledge about 
the cause of their disease, and 579 patients (54%) wanted 
more general information on their disease.
 In none of the questions were gender and type of IBD 
significantly associated with patients’ assessments of 
shared decision-making.
 Shared Decision-Making among Patients in the 
Outpatient Clinic Group 
 In total, 169 patients from our outpatient IBD clinic 
completed the questionnaire: 125 had CD (74%), 41 had 
UC (24%), and 3 patients had unclassified colitis (2%). 
The mean age of patients was 38.7 (SD 14.4) years old, 
duration of disease was  1 8 years in 93 patients (55%), and 
84 patients (50%) were female. Of the outpatient clinic 
group, 61 patients (36%) were member of the CCUVN. 
Patient characteristics are shown in  table 1 . Patients’ sat-
isfaction concerning current treatment in the outpatient 
clinic group are listed in  table 2 . Compared with patients 
in the online group, IBD patients in the outpatient clinic 
group are more satisfied with the time and attention that 
is given to them during their visit to the IBD clinic (p = 
0.04). Both groups are equally satisfied with their current 
treatment and their involvement in this treatment.
 Patients’ preferences regarding shared decision-mak-
ing are demonstrated and compared with the preferences 
of those in the online group in  table 4 . In total, 147 pa-
tients (87%) called it ‘very important’ to be actively in-
volved in the decision of their medical treatment options. 
Another 18 patients (11%) rated active involvement in this 
n
Number 1,067
Close collaboration with the physician, based on equivalence 537 (50%)
More knowledge of the cause of disease 496 (47%)
More knowledge of disease in general 427 (40%)
More knowledge of any new medications 579 (54%)
A checklist to fill out, improve treatment in close consultation
with physician 289 (27%)
More knowledge of what the doctor needs to be able to improve
treatment
232 (22%)
Information on websites, flyers and current research 384 (36%)
To get in touch with fellow-sufferers or hands-on experts 324 (30%)
Table 3. Patients’ suggestions to improve 
current treatment in the online group
Very
important
0
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n
ts
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Quite
important
Quite
unimportant
Totally
unimportant
n = 1,067
0
200
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800
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,n
p = 0.03
8 years of disease< >8 years of disease
 Fig. 1. IBD patients’ assessments of shared decision-making.  Fig. 2. IBD patients’ demands for improving treatment: good col-
laboration with physician, based on equivalence. 
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decision process as ‘quite important’. This percentage was 
even higher compared to the online group (p = 0.03). A 
close equitable collaboration with their physician was re-
quested by 112 patients (67%). This percentage was sig-
nificantly higher compared to the online group (p  ! 
0.001).
 Discussion 
 This large survey demonstrates that a significant pro-
portion of patients with IBD prefer active involvement in 
the decision-making process of the treatment of their dis-
ease. Half of these patients want an equitable relationship 
with their physician to improve their treatment regimen, 
and more than half of all patients want to be better in-
formed about their disease and new medication options. 
Patients with a shorter duration of disease report prefer-
ring more involvement in the decision-making process. 
This can be explained by the fact that these patients are 
more often in the active phase of their disease and there-
fore need frequent adjustments in their treatment strat-
egy  [26] .
 Patient participation in decision-making has been ad-
vocated for many reasons. Patients who are active par-
ticipants in the process of their care, e.g. asking ques-
tions, expressing their opinions and stating preferences 
regarding treatment, have measurably better health out-
comes than patients who do not participate in the deci-
sion-making  [2, 5, 13, 15, 27] . Patients who feel that they 
have participated in decision-making are also more like-
ly to follow through on those decisions than patients who 
do not participate in this process. This is very important 
in a chronic disease such as IBD, since non-adherence to 
therapy is one of the many possible reasons for relapsing 
disease  [25] . Moreover, non-adherence is in general asso-
ciated with higher healthcare costs and in the case of 5-
ASA medication, non-adherence may even be associated 
with a higher risk of colorectal cancer  [28] . Improving 
adherence is therefore of great importance for improving 
health outcomes in IBD.
 Since shared decision-making is based on collabora-
tion between patients and doctors, not only patients’ per-
spectives are of interest for shared decision-making, but 
doctors’ perspectives and preferences should be included 
as well. However, there are relatively few studies on physi-
cians’ preferences for decision-making  [29–31] . A cross-
sectional survey of a nationally representative sample of 
US physicians demonstrated that 75% of the physicians 
(780/1,050) preferred to share the decision-making with 
their patients  [2, 30] . Nonetheless, data on preferences of 
doctors treating especially chronically ill patients, such 
as IBD patients, are lacking.
 Another factor that involves shared decision-making 
is the working knowledge base which is influenced by re-
search evidence and evaluation and synthesizing of the 
evidence. In a chronic disease such as IBD, patients need 
to be treated with specific medication which has to be 
taken consequently and most often has to be continued 
indefinitely. Each kind of treatment has its own possible 
benefits, risks and side effects, and there is considerable 
variability in the progression of the disease in individual 
patients and patients’ individual responses to medica-
tion. This complicates the implementation of shared de-
cision-making in the treatment of IBD. Further research 
on predictive factors for individual response to therapies 
is necessary to develop a model for shared decision-mak-
ing in IBD. Based on these predictive factors, not only 
physicians but also patients should be able to decide 
which side effects and treatment-associated risks they are 
willing to accept for a possible treatment benefit  [32] . In 
shared decision-making, information on treatment op-
tions is exchanged and patients are involved in the final 
decision.
 Internet surveys are generally limited by their lack of 
information on response rates and generalizability. The 
CCUVN has approximately 10,250 members, of whom 
9,509 have registered their gender and age. Of all mem-
bers, only 10% filled out our questionnaire, which was 
however fully representative for all CCUVN members 
with regard to age and gender. Additional patient charac-
teristics of the total CCUVN population are unknown 
and the representativeness of our respondents based on 
Table 4. Patients’ preferences on shared decision-making in the 
online group and outpatient clinic group
Online
group
Outpatient 
clinic group
p value
Overall assessment of shared decision-making
Very important 866 (81%) 147 (87%)
Quite important 177 (17%) 18 (11%)
Quite unimportant 13 (1%) 2 (1%) 0.003
Totally unimportant 11 (1%) –
No answer given – 2 (1%)
Requesting a close, equitable collaboration
with their physician
537 (50%) 112 (67%) <0.001
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the type of IBD cannot be verified. However, type of IBD 
was not significantly associated with patients’ preferenc-
es of shared decision-making.
 We recognize that our respondents are all CCUVN 
members and therefore are not representative of all Dutch 
IBD patients. Therefore a control group of IBD patients 
from an outpatient IBD practice was used. These patients 
showed even a higher preference rate for shared decision-
making and therefore verified the preferences from the 
online population.
 Another limitation of our study is that information is 
lacking on current clinical practice with regard to shared 
decision-making. Our aim was solely to assess patients’ 
preferences on decision-making and the extent to which 
they wish to be involved in this process. Our study pres-
ents a new focus to improve standard care and to be able 
to develop a model to implement shared decision-making 
in clinical practice in the future.
 This study is a patient-empowerment study and uses a 
non-validated questionnaire which was developed by 
IBD patients to obtain pure information on patients’ pref-
erences. Using a patient-based questionnaire distributed 
through the internet, we were able to reach a large nation-
wide patient group while obtaining information anony-
mously without intentional or unintentional interference 
by healthcare providers. A group from our outpatient 
IBD clinic was used as control group to verify the results. 
This group confirmed the need for shared decision-mak-
ing in IBD patients.
 In conclusion, this patient-empowerment study dem-
onstrates that IBD patients prefer active involvement in 
the decision-making process concerning the treatment of 
their disease. This is of importance to respect patients as 
persons, but above all to improve health outcomes. Lim-
ited data are available on factors influencing shared deci-
sion-making in IBD. It is therefore a challenge to imple-
ment shared decision-making in the healthcare of IBD in 
the future. Further research is needed on physicians’ per-
spectives on shared decision-making and on developing 
a model to implement shared decision-making in clinical 
practice using predictive factors. Nonetheless, our results 
demonstrate that most IBD patients are ready to imple-
ment shared decision-making to improve their treatment 
strategy. 
Appendix: The questionnaire
What type of inflammatory bowel disease (IBD) do you have?
(a) Crohn’s disease (c) Unclassified colitis
(b) Ulcerative colitis
How long has it been since you were diagnosed with IBD?
(a) 0–2 years (c) 9–15 years
(b) 3–8 years (d) longer than 15 years
What is your gender?
(a) Male (b) Female
How old are you?
           years old
Are you a member of the Dutch Crohn’s and Colitis organization 
(CCUVN)?
(a) Yes (b) No
If you think about the decisions your physician makes concern-
ing your medical treatment, how satisfied are you with the extent 
to which your physician involves you in these decisions?
(a) Very satisfied (c) Dissatisfied
(b) Satisfied (d) Very dissatisfied
How important is it for you that your physician involves you in 
the decisions concerning your medical treatment?
(a) Very important (c) Quite unimportant
(b) Quite important (d) Totally unimportant
How satisfied are you with the time and attention that your phy-
sician spends on you during your visits to the outpatient clinic?
(a) Very satisfied (c) Dissatisfied
(b) Satisfied (d) Very dissatisfied
Do you think that your medical treatment prescribed by your 
physician could be improved?
(a) Yes (b) No
How could the treatment prescribed by your physician be
improved?
........................................................................................................................................
What does a patient like you need to know/receive to be able to 
get better treatment for your disease (multiple answers may be 
given) 
(a) More knowledge of the cause of my disease
(b) More knowledge of my disease in general
(c) More knowledge of any new medications
(and when they are in particular suitable)
(d) A checklist to fill out, so my doctor and I can improve 
my treatment in close consultation
(e) More information on what my doctor needs to be able to 
improve my treatment
(f) A close collaboration with my doctor based on
equivalence
(g) Information on websites, flyers and current research
(h) To get in touch with fellow sufferers or hands-on experts
(i) Nothing
Do you have any suggestions to improve collaboration with your 
treating physician?
........................................................................................................................................
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